Hospira Epirubicin Hydrochloride Injection 50mg/25mL Hospira

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

epirubicin hydrochloride, Quantity: 2 mg/mL

Pieejams no:

Hospira Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

epirubicin hydrochloride

Zāļu forma:

Injection, solution

Kompozīcija:

Excipient Ingredients: sodium chloride; water for injections

Ievadīšanas:

Intravenous Infusion

Vienības iepakojumā:

1 Vial per pack

Klase:

Medicine Listed (Export Only)

Receptes veids:

(S1) This Schedule is intentionally blank

Ārstēšanas norādes:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

Produktu pārskats:

Visual Identification: Epirubicin Hydrochloride Injeciton is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2013-05-08